Relationship between STK11 and KEAP1 mutational status and efficacy in KEYNOTE-042: pembrolizumab monotherapy versus platinum-based chemotherapy as first-line therapy for PD-L1-positive advanced NSCLC-MedSci.cn

Relationship between STK11 and KEAP1 mutational status and efficacy in KEYNOTE-042: pembrolizumab monotherapy versus platinum-based chemotherapy as first-line therapy for PD-L1-positive advanced NSCLC

Cho, BC; Lopes, G; Kowalski, DM; Kasahara, K; Wu, YL; Castro, G; Turna, HZ; Cristescu, R; Aurora-Garg, D; Loboda, A; Lunceford, J; Kobie, J; Ayers, M; Pietanza, MC; Piperdi, B; Mok, TS

CANCER RESEARCH, 2020; 80 (16):

科室
- - 订阅+
  - 更多科室
工具
服务